It was reported that CD163+ tumor-associated macrophages could inhibit T-cell proliferation and activation by secreting CCL22, IL-10, and TGF-β and recruiting regulatory T cells (Tregs) to tumor tissues (22, 23). This evidence concerns the gene CD163 and neoplasm.